$ALNY ALNYLAM PHARMACEUTICALS, INC. Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0001178670
IRS Number: 770602661
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALNY
Company Address: 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE 02142
Former name: ALNYLAM PHARMACEUTICALS INC, date of change: 2002-07-24

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Market Capitalization: $3.49B
Prev close: $40.46
Average Daily Volume: 1,254,630
Days Low: $39.66
Year Low: $31.38
Year High: $80.11

ALNYLAM PHARMACEUTICALS, INC. Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Option Exercise	M	7.10	33,979	241,251	67,957
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	134.37	1,023	137,461	214,765	215.8 K to 214.8 K (-0.47 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	133.56	1,624	216,901	215,788	217.4 K to 215.8 K (-0.75 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	132.32	3,481	460,606	217,412	220.9 K to 217.4 K (-1.58 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	131.18	11,203	1,469,610	220,893	232.1 K to 220.9 K (-4.83 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	130.34	9,121	1,188,831	232,096	241.2 K to 232.1 K (-3.78 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	129.32	4,512	583,492	241,217	245.7 K to 241.2 K (-1.84 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Sell	S	128.30	3,015	386,825	245,729	248.7 K to 245.7 K (-1.21 %)
May 17 2021	ALNY	ALNYLAM PHARMACEUT ...	MARAGANORE JOHN	Chief Executive Off ...	Buy	M	7.10	33,979	241,251	248,744	214.8 K to 248.7 K (+15.82 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Sell	S	138.48	107	14,817	14,119	14.2 K to 14.1 K (-0.75 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Sell	S	137.60	530	72,928	14,226	14.8 K to 14.2 K (-3.59 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Sell	S	136.84	1,892	258,901	14,756	16.6 K to 14.8 K (-11.36 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Sell	S	135.41	203	27,488	16,648	16.9 K to 16.6 K (-1.20 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Payment of Exercise	F	134.56	85	11,438	16,851	16.9 K to 16.9 K (-0.50 %)
Apr 21 2021	ALNY	ALNYLAM PHARMACEUT ...	Vaishnaw Akshay	President, R&D	Payment of Exercise	F	131.75	2,266	298,546	16,936	19.2 K to 16.9 K (-11.80 %)

View all ALNYLAM PHARMACEUTICALS, INC. insider transactions.